Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Harini Sarva & Claire Henchcliffe. (2018) Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Expert Review of Clinical Pharmacology 11:3, pages 209-217.
Read now
Read now
J. Peuskens, J.M. Devoitille, J. Kusters & G. Vandenhoven. (2008) An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder. International Journal of Psychiatry in Clinical Practice 12:4, pages 261-267.
Read now
Read now
Articles from other publishers (25)
Clément Dondé, Caroline Dubertret, Guillaume Fond, Myrtille Andre, Fabrice Berna, Laurent Boyer, Delphine Capdevielle, Isabelle Chereau, Nathalie Coulon, Jean-Michel Dorey, Sylvain Leignier, Pierre-Michel Llorca, David Misdrahi, Christine Passerieux, Baptiste Pignon, Romain Rey, Benoît Schorr, Franck Schürhoff, Mathieu Urbach, Mircea Polosan & Jasmina Mallet. (2022) History of learning disorders is associated with worse cognitive and functional outcomes in schizophrenia: results from the multicentric FACE-SZ cross-sectional dataset. European Archives of Psychiatry and Clinical Neuroscience 273:8, pages 1773-1783.
Crossref
Crossref
Zixu Yang, Hiroyoshi Takeuchi, Jie Yin Yee, Yuen Mei See, Charmaine Tang, Boon Tat Ng & Jimmy Lee. (2023) Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore. Schizophrenia Research.
Crossref
Crossref
Paul P. YeungKimball A. JohnsonRobert RiesenbergAmelia OrejudosTodd Riccobene, Hari V. Kalluri, Paul R. MalikShane VarugheseRobert L. Findling. (2023) Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study. Journal of Child and Adolescent Psychopharmacology 33:6, pages 232-242.
Crossref
Crossref
Vanteemar S. Sreeraj, Venkataram Shivakumar, Gaurav V. Bhalerao, Sunil V. Kalmady, Janardhanan C. Narayanaswamy & Ganesan Venkatasubramanian. (2023) Resting-state functional connectivity correlates of antipsychotic treatment in unmedicated schizophrenia. Asian Journal of Psychiatry 82, pages 103459.
Crossref
Crossref
Aysegul Tonyali, Gul Karacetin, Celal Yesilkaya, Feyza Nur Tas Arik & Binay Kayan Ocakoglu. (2023) Appearance of extrapyramidal symptoms in adolescent psychiatry patients during COVID‐19 infection. Journal of Medical Virology 95:2.
Crossref
Crossref
Cristian Petrescu, Ioana R. Papacocea, Crisanda Vilciu, Oana A. Mihalache, Diana M. Vlad, Gabriela Marian, Brindusa E. Focseneanu, Cristian T. Sima, Constantin A. Ciobanu, Sorin Riga & Adela M. Ciobanu. (2022) The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia. Biomedicines 10:11, pages 2939.
Crossref
Crossref
Todd Riccobene, Robert RiesenbergPaul P. YeungWillie R. EarleyArlene L. Hankinson. (2022) Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia. Journal of Child and Adolescent Psychopharmacology 32:8, pages 434-443.
Crossref
Crossref
Gurpreet Rekhi, Jenny Tay & Jimmy Lee. (2022) Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia. Journal of Psychopharmacology 36:2, pages 183-190.
Crossref
Crossref
Tarek K. Rajji, David C. Mamo, Jason Holden, Eric Granholm & Benoit H. Mulsant. (2022) Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction. Schizophrenia Research 239, pages 160-167.
Crossref
Crossref
Rolf-Dieter Stieglitz & Hans-Peter Volz. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
245
267
.
Saeed Ahmed, Robert M. Roth, Corneliu N. Stanciu & Mary F. Brunette. (2021) The Impact of THC and CBD in Schizophrenia: A Systematic Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Lana Ganoci, Vladimir Trkulja, Maja Živković, Tamara Božina, Marina Šagud, Mila Lovrić & Nada Božina. (2021) ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone. Progress in Neuro-Psychopharmacology and Biological Psychiatry 104, pages 110042.
Crossref
Crossref
Abraham Goldring, Sophia Borne, Amanda Hefner, Amod Thanju, Anzalee Khan & Jean-Pierre Lindenmayer. (2020) The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS). Schizophrenia Research 224, pages 159-166.
Crossref
Crossref
Marlene Schouby Bock, Oona Nørgaard Van Achter, David Dines, Maria Simonsen Speed, Christoph U Correll, Ole Mors, Søren Dinesen Østergaard & Pernille Kølbæk. (2020) Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference. Journal of Psychopharmacology 34:8, pages 820-828.
Crossref
Crossref
Michael S. Kraus, James M. Gold, Deanna M. Barch, Trina M. Walker, Charlotte A. Chun, Robert W. Buchanan, John G. Csernansky, Donald C. Goff, Michael F. Green, L. Fredrik Jarskog, Daniel C. Javitt, David Kimhy, Jeffrey A. Lieberman, Joseph P. McEvoy, Raquelle I. Mesholam-Gately, Larry J. Seidman, M. Patricia Ball, Robert S. Kern, Robert P. McMahon, James Robinson, Stephen R. Marder & Richard S.E. Keefe. (2020) The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophrenia Research: Cognition 19, pages 100161.
Crossref
Crossref
Rolf-Dieter Stieglitz & Hans-Peter Volz. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
24
.
Hannah O'Brien, Fiona Kiely, Aileen Barry & Sarah Meaney. (2019) Cross-sectional examination of extrapyramidal side effects in a specialist palliative care inpatient unit. BMJ Supportive & Palliative Care 9:3, pages 271-273.
Crossref
Crossref
Tania M. Lincoln, Sonia Dollfus & John Lyne. (2017) Current developments and challenges in the assessment of negative symptoms. Schizophrenia Research 186, pages 8-18.
Crossref
Crossref
Evan Mayo-Wilson, Susan Hutfless, Tianjing Li, Gillian Gresham, Nicole Fusco, Jeffrey Ehmsen, James Heyward, Swaroop Vedula, Diana Lock, Jennifer Haythornthwaite, Jennifer L. Payne, Theresa Cowley, Elizabeth Tolbert, Lori Rosman, Claire Twose, Elizabeth A. Stuart, Hwanhee Hong, Peter Doshi, Catalina Suarez-Cuervo, Sonal Singh & Kay Dickersin. (2015) Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review. Systematic Reviews 4:1.
Crossref
Crossref
Dean Elbe, Edel Mc Glanaghy & Tim F. Oberlander. 2015. The Science and Ethics of Antipsychotic Use in Children. The Science and Ethics of Antipsychotic Use in Children
27
64
.
Wilma Knol, Rob J. van Marum, Paul A.F. Jansen, Eric Strengman, Asmar F.Y. Al Hadithy, Bob Wilffert, Alfred F.A.M. Schobben, Roel A. Ophoff & Toine C.G. Egberts. (2013) Genetic Variation and the Risk of Haloperidol-Related Parkinsonism in Elderly Patients. Journal of Clinical Psychopharmacology 33:3, pages 405-410.
Crossref
Crossref
Eva Choong, Andrea Polari, Rigobert Hervais Kamdem, Nicola Gervasoni, Caesar Spisla, Eveline Jaquenoud Sirot, Graziella Giacometti Bickel, Guido Bondolfi, Philippe Conus & Chin B. Eap. (2013) Pharmacogenetic Study on Risperidone Long-Acting Injection. Journal of Clinical Psychopharmacology 33:3, pages 289-298.
Crossref
Crossref
Henrike J. Schouten, Wilma Knol, Toine C.G. Egberts, Alfred F.A.M. Schobben, Paul A.F. Jansen & Rob J. van Marum. (2012) Quality of Life of Elderly Patients With Antipsychotic-Induced Parkinsonism: A Cross-Sectional Study. Journal of the American Medical Directors Association 13:1, pages 82.e1-82.e5.
Crossref
Crossref
Wilma Knol, Carolina J.P.W. Keijsers, Paul A.F. Jansen & Rob J. van Marum. (2010) Systematic Evaluation of Rating Scales for Drug-Induced Parkinsonism and Recommendations for Future Research. Journal of Clinical Psychopharmacology 30:1, pages 57-63.
Crossref
Crossref
Wilma Knol, Carolina J. P. W. Keijsers, Paul A. F. Jansen, Svetlana V. Belitser, Alfred F. A. M. Schobben, Antoine C. G. Egberts & Rob J. van Marum. (2008) Validity and reliability of the Simpson‐Angus Scale (SAS) in drug induced parkinsonism in the elderly. International Journal of Geriatric Psychiatry 24:2, pages 183-189.
Crossref
Crossref